Halozyme Therapeutics Inc (HALO)

[rod5247]

Joel Beatty - Citigroup
Sure and thanks. And then another question on the ENHANZE platform with Pfizer previously making comments about using a technology with the PCSK9 product, and then Roche also commenting about using your product with Gazyva – could 2015 be set up for a busy year and is slow with partnering with these programs and others for the ENHANZE platform?
Helen Torley - President and CEO
Joel, thank you. I mean that really – as we looked at the portfolio assessment of where the opportunities lie, we landed on PEGPH20 but also ENHANZE for exactly the reasons you talked about. Since we have seen the approval of HyQvia in the US and since the launched success of Herceptin has been noted, we definitely have seen a lot of increased interest in ENHANZE; so not just with our current partners but in new partners. So, yes, that certainly is our goal to have a lot of news flow in ENHANZE in 2015.

From seekingalpha.com q3 transcript update. Fezz from ymb evidently got this correction. It was clear on the call audio.